Search

Learn how a successful clinical trial for pancreatic cancer in which MSK experts play a leading role is opening a new world of treatment options.

… Sunday, May 31, 2026 A highly anticipated clinical trial of the targeted drug daraxonrasib suggests it may open a whole new era in treating pancreatic cancer , after the drug doubled median survival time for patients compared with chemotherapy . People in the trial also tolerated side effects from the

A clinical trial led by doctors from MSK has found that abemaciclib — a drug already approved for certain breast cancers — can significantly slow the growth of dedifferentiated liposarcoma, a rare, aggressive soft tissue cancer.

… Sunday, May 31, 2026 Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now a clinical trial led by doctors from Memorial Sloan Kettering Cancer Center (MSK) has found that abemaciclib (Verzenio ® ) — a drug already approved for certain

Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery.

… Thursday, May 28, 2026   This story was originally published in 2017 and was last updated in May 2026. After a decade of research seeking ways to make radiation treatment easier for patients, doctors at Memorial Sloan Kettering Cancer Center (MSK) have confirmed that many HPV-positive throat cancer patients